COMPANY

Cloverleaf Bio, Inc.

HQ: New Haven, CT source · cloverleafbio.com ↗

3 open jobs · last seen Oct 23, 2026

Keywords: From press sources:RNA therapeutics renal

Location: New Haven, CT · source · Sep 9, 2026

Profile checked Oct 10, 2026

Open jobs 3

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Research Associate	Boston, MA	Oct 13, 2026	Oct 11, 2026	Entry
Scientist, In Vivo Cancer Modeling	Boston, MA	Oct 5, 2026	Oct 11, 2026	Mid
Scientist, RNA Biochemistry	Boston, MA	Sep 7, 2026	Oct 11, 2026	Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Hiring

Title	Location (from posting)	Employer posted	First seen
Research Associate	Boston, MA	Oct 13, 2026	Oct 11, 2026
Scientist, In Vivo Cancer Modeling	Boston, MA	Oct 5, 2026	Oct 11, 2026
Scientist, RNA Biochemistry	Boston, MA	Sep 7, 2026	Oct 11, 2026

See all 3 jobs

Funding and NIH signals

SEC Form D raise Raised $14.8M (Form D filed Sep 9, 2026); 3 roles open. SEC Form D 0002153574-26-000001 (Sep 9, 2026)
Evidence (1 event)
- Sep 9, 2026 · SEC Form D 0002153574-26-000001
  Name of Issuer: Cloverleaf Bio, Inc.; CIK: 2153574; Address: New Haven, CT; Submission type: D; Filing date: 2026-09-09; Industry Group: Biotechnology; Date of First Sale: 2026-08-24; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 29599977; Total Amount Sold: 14799988; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals